Annual EBITDA:
-$173.63M-$136.60M(-368.90%)Summary
- As of today, SLNO annual EBITDA is -$173.63 million, with the most recent change of -$136.60 million (-368.90%) on December 31, 2024.
- During the last 3 years, SLNO annual EBITDA has fallen by -$143.34 million (-473.12%).
- SLNO annual EBITDA is now -21471.87% below its all-time high of -$804.90 thousand, reached on December 31, 2013.
Performance
SLNO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$2.83M+$39.08M(+93.25%)Summary
- As of today, SLNO quarterly EBITDA is -$2.83 million, with the most recent change of +$39.08 million (+93.25%) on June 30, 2025.
- Over the past year, SLNO quarterly EBITDA has increased by +$18.53 million (+86.75%).
- SLNO quarterly EBITDA is now -243.69% below its all-time high of $1.97 million, reached on March 31, 2013.
Performance
SLNO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$173.05M+$18.53M(+9.67%)Summary
- As of today, SLNO TTM EBITDA is -$173.05 million, with the most recent change of +$18.53 million (+9.67%) on June 30, 2025.
- Over the past year, SLNO TTM EBITDA has dropped by -$109.25 million (-171.25%).
- SLNO TTM EBITDA is now -8886.44% below its all-time high of $1.97 million, reached on March 31, 2013.
Performance
SLNO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SLNO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -368.9% | +86.8% | -171.3% |
| 3Y3 Years | -473.1% | +50.1% | -595.2% |
| 5Y5 Years | -717.5% | +64.0% | -495.6% |
SLNO EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -685.6% | at low | at high | +96.4% | -682.9% | +9.7% |
| 5Y | 5-Year | -717.5% | at low | at high | +96.4% | -682.9% | +9.7% |
| All-Time | All-Time | >-9999.0% | at low | -243.7% | +96.4% | -8886.4% | +9.7% |
SLNO EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$2.83M(+93.2%) | -$173.05M(+9.7%) |
| Mar 2025 | - | -$41.91M(+15.3%) | -$191.58M(-12.3%) |
| Dec 2024 | -$173.63M(-368.9%) | -$49.48M(+37.2%) | -$170.58M(-27.5%) |
| Sep 2024 | - | -$78.83M(-269.1%) | -$133.76M(-109.7%) |
| Jun 2024 | - | -$21.36M(-2.2%) | -$63.80M(-26.9%) |
| Mar 2024 | - | -$20.91M(-65.2%) | -$50.26M(-35.7%) |
| Dec 2023 | -$37.03M(-67.5%) | -$12.66M(-42.7%) | -$37.03M(-27.5%) |
| Sep 2023 | - | -$8.87M(-13.4%) | -$29.05M(-12.6%) |
| Jun 2023 | - | -$7.82M(-1.8%) | -$25.79M(-9.1%) |
| Mar 2023 | - | -$7.68M(-64.0%) | -$23.64M(-7.0%) |
| Dec 2022 | -$22.10M(+27.0%) | -$4.68M(+16.6%) | -$22.10M(+5.0%) |
| Sep 2022 | - | -$5.61M(+1.1%) | -$23.26M(+6.6%) |
| Jun 2022 | - | -$5.67M(+7.6%) | -$24.89M(+7.1%) |
| Mar 2022 | - | -$6.14M(-5.2%) | -$26.78M(+11.6%) |
| Dec 2021 | -$30.30M(-1.0%) | -$5.84M(+19.4%) | -$30.30M(+4.7%) |
| Sep 2021 | - | -$7.24M(+4.2%) | -$31.79M(-2.1%) |
| Jun 2021 | - | -$7.56M(+21.7%) | -$31.14M(+1.0%) |
| Mar 2021 | - | -$9.65M(-31.7%) | -$31.44M(-4.8%) |
| Dec 2020 | -$30.00M(-41.2%) | -$7.33M(-11.1%) | -$30.00M(-3.2%) |
| Sep 2020 | - | -$6.59M(+16.1%) | -$29.06M(-3.5%) |
| Jun 2020 | - | -$7.86M(+4.2%) | -$28.08M(-11.6%) |
| Mar 2020 | - | -$8.21M(-28.5%) | -$25.16M(-18.5%) |
| Dec 2019 | -$21.24M | -$6.39M(-13.8%) | -$21.24M(-18.5%) |
| Sep 2019 | - | -$5.62M(-13.4%) | -$17.92M(-15.9%) |
| Jun 2019 | - | -$4.95M(-15.6%) | -$15.46M(-14.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$4.28M(-39.6%) | -$13.50M(-14.7%) |
| Dec 2018 | -$11.77M(-4.7%) | -$3.07M(+2.9%) | -$11.77M(+15.9%) |
| Sep 2018 | - | -$3.16M(-5.7%) | -$14.00M(-7.6%) |
| Jun 2018 | - | -$2.99M(-17.0%) | -$13.01M(-3.8%) |
| Mar 2018 | - | -$2.56M(+51.8%) | -$12.54M(-11.6%) |
| Dec 2017 | -$11.24M(-35.3%) | -$5.30M(-143.9%) | -$11.24M(-44.9%) |
| Sep 2017 | - | -$2.17M(+13.7%) | -$7.76M(-2.7%) |
| Jun 2017 | - | -$2.52M(-100.7%) | -$7.55M(-3.4%) |
| Mar 2017 | - | -$1.25M(+30.9%) | -$7.31M(+29.0%) |
| Dec 2016 | -$8.31M(+31.1%) | -$1.82M(+7.8%) | -$10.30M(-36.8%) |
| Sep 2016 | - | -$1.97M(+13.3%) | -$7.53M(+14.7%) |
| Jun 2016 | - | -$2.27M(+46.5%) | -$8.83M(+7.9%) |
| Mar 2016 | - | -$4.24M(-545.5%) | -$9.58M(-23.6%) |
| Dec 2015 | -$12.05M(-32.7%) | $952.50K(+129.2%) | -$7.75M(+46.5%) |
| Sep 2015 | - | -$3.27M(-7.8%) | -$14.49M(-15.5%) |
| Jun 2015 | - | -$3.03M(-25.6%) | -$12.54M(-16.0%) |
| Mar 2015 | - | -$2.41M(+58.3%) | -$10.81M(-22.3%) |
| Dec 2014 | -$9.08M(-1027.9%) | -$5.78M(-339.2%) | -$8.84M(-138.3%) |
| Sep 2014 | - | -$1.32M(-1.3%) | -$3.71M(-55.0%) |
| Jun 2014 | - | -$1.30M(-196.1%) | -$2.39M(-4.7%) |
| Mar 2014 | - | -$439.00K(+32.9%) | -$2.29M(-1955.0%) |
| Dec 2013 | -$804.90K(+77.5%) | -$653.90K(+45.2%) | $123.20K(-84.1%) |
| Jun 2013 | - | -$1.19M(-160.5%) | $777.10K(-60.5%) |
| Mar 2013 | - | $1.97M | $1.97M |
| Dec 2012 | -$3.57M | - | - |
FAQ
- What is Soleno Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Soleno Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Soleno Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Soleno Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of SLNO is -$173.63M
What is the all-time high annual EBITDA for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high annual EBITDA is -$804.90K
What is Soleno Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, SLNO annual EBITDA has changed by -$136.60M (-368.90%)
What is Soleno Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of SLNO is -$2.83M
What is the all-time high quarterly EBITDA for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high quarterly EBITDA is $1.97M
What is Soleno Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, SLNO quarterly EBITDA has changed by +$18.53M (+86.75%)
What is Soleno Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of SLNO is -$173.05M
What is the all-time high TTM EBITDA for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high TTM EBITDA is $1.97M
What is Soleno Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, SLNO TTM EBITDA has changed by -$109.25M (-171.25%)